XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
CURRENT ASSETS    
Cash and cash equivalents $ 147,630 $ 240,420
Marketable securities, short-term 206,101 135,412
Accounts receivable 374 1,153
Contract assets 1,494 1,488
Other receivables 4,169 5,483
Prepaid expenses and other current assets 8,242 7,236
Total current assets 368,010 391,192
Investments in equity securities 7,666 7,626
Marketable securities, long-term 37,092 37,676
Property and equipment - net 6,016 4,887
Operating lease, right of use asset 25,749 0
Other assets 1,464 975
TOTAL ASSETS 445,997 442,356
CURRENT LIABILITIES:    
Accounts payable 1,814 3,990
Accrued expenses and other current liabilities 11,190 13,136
Lease liabilities 825 0
Deferred revenue 12,838 8,703
Total current liabilities 26,667 25,829
LONG-TERM LIABILITIES    
Deferred revenue, net of current portion ($100 and $100 from related party) 17,326 22,032
Deferred rent and lease incentive liability 0 2,097
MSKCC success payments liability 2,484 4,080
Lease liabilities, non-current 27,238 0
Other liabilities 9 17
Deferred tax liabilities 476 476
Total liabilities 74,200 54,531
COMMITMENTS AND CONTINGENCIES (Note 9)
STOCKHOLDERS' EQUITY    
Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized at March 31, 2022 and December 31, 2021; no shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively. 0 0
Common stock, par value $0.0001 per share 300,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively; 60,689,609 and 60,263,158 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 6 6
Additional paid-in-capital 489,762 485,748
Accumulated other comprehensive loss (1,089) (135)
Accumulated deficit (116,882) (97,794)
Total stockholders' equity 371,797 387,825
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 445,997 $ 442,356